Literature DB >> 18015689

Vaccine Prophylaxis against Tularemia in Man.

L Foshay, W H Hesselbrock, H J Wittenberg, A H Rodenberg.   

Abstract

Entities:  

Year:  1942        PMID： 18015689      PMCID： PMC1527181          DOI： 10.2105/ajph.32.10.1131

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  30 in total

1.  CHRONIC BRUCELLOSIS: A FOLLOW-UP STUDY OF 133 PATIENTS TREATED WITH OXIDIZED VACCINE.

Authors:  J F Griggs
Journal:  Calif Med       Date:  1948-09

2.  Public Health Weekly Reports for JUNE 29, 1945.

Authors: 
Journal:  Public Health Rep       Date:  1945-06-29       Impact factor: 2.792

3.  Survey of laboratory-acquired infections.

Authors:  S E SULKIN; R M PIKE
Journal:  Am J Public Health Nations Health       Date:  1951-07

4.  Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.

Authors:  M S Ascher; D Parker; J L Turk
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

5.  Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.

Authors:  Douglas S Reed; Le'kneitah P Smith; Kelly Stefano Cole; Araceli E Santiago; Barbara J Mann; Eileen M Barry
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

6.  Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components.

Authors:  P Hambleton; C G Evans; A M Hood; R E Strange
Journal:  Br J Exp Pathol       Date:  1974-08

Review 7.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

Review 8.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 9.  Vaccines against tularemia.

Authors:  Eileen M Barry; Leah E Cole; Araceli E Santiago
Journal:  Hum Vaccin       Date:  2009-12-11

10.  Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.

Authors:  Damiana Chiavolini; Susan Weir; John R Murphy; Lee M Wetzler
Journal:  Clin Vaccine Immunol       Date:  2008-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.